Company
BB Biotech AG
Headquarters: Kusnacht, Switzerland
Employees: 10
Market Cap
CHF3.15 Billion
CHF as of Jan. 1, 2023
US$3.41 Billion
BB Biotech AG Categories
Switzerland
languages
Healthcare
languages
Biotechnology
Switzerland Healthcare
Switzerland Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
Novo Nordisk
|
$304.61 B |
CSL Limited
|
$93.24 B |
Regeneron Pharmaceuticals, Inc.
|
$79.53 B |
| Marinomed Biotech AG | $76.72 B |
|
Vertex Pharmaceuticals Incorporated
|
$74.13 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$495.37 B |
|
Johnson & Johnson
|
$461.85 B |
|
Lilly
|
$347.61 B |
|
Novo Nordisk
|
$304.61 B |
|
Pfizer
|
$287.63 B |
Detailed Description
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Stocks & Indices
BB Biotech AG has the following listings and related stock indices.
Stock: SIX: BION
Stock: MTA: BB
Stock: OTC: BBAGF